ArticleJournal of clinical & cellular immunology2015

Prostate Cancer Immunotherapy: Exploiting the HLA Class II Pathway in Vaccine Design.

Bently P Doonan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.